These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 15313947

  • 21. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus.
    Sidhu JS, Cowan D, Kaski JC.
    Am J Cardiol; 2004 Jul 15; 94(2):151-6. PubMed ID: 15246889
    [Abstract] [Full Text] [Related]

  • 22. Fluvastatin blunts the effect of a high-fat meal on plasma triglyceride and high-sensitivity C-reactive protein concentrations in patients at high risk for cardiovascular events.
    Liu L, Zhao SP, Hu M, Li JX.
    Coron Artery Dis; 2007 Sep 15; 18(6):489-93. PubMed ID: 17700222
    [Abstract] [Full Text] [Related]

  • 23. Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.
    Liu L, Zhao SP, Cheng YC, Li YL.
    Clin Chem; 2003 Aug 15; 49(8):1347-52. PubMed ID: 12881451
    [Abstract] [Full Text] [Related]

  • 24. The acute effect of various glycemic index dietary carbohydrates on endothelial function in nondiabetic overweight and obese subjects.
    Lavi T, Karasik A, Koren-Morag N, Kanety H, Feinberg MS, Shechter M.
    J Am Coll Cardiol; 2009 Jun 16; 53(24):2283-7. PubMed ID: 19520253
    [Abstract] [Full Text] [Related]

  • 25. Artichoke juice improves endothelial function in hyperlipemia.
    Lupattelli G, Marchesi S, Lombardini R, Roscini AR, Trinca F, Gemelli F, Vaudo G, Mannarino E.
    Life Sci; 2004 Dec 31; 76(7):775-82. PubMed ID: 15581909
    [Abstract] [Full Text] [Related]

  • 26. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
    Hu CL, Li YB, Tang YH, Chen JB, Liu J, Tang QZ, Zhang QH, Huang CX.
    Cardiovasc Drugs Ther; 2006 Jun 31; 20(3):185-91. PubMed ID: 16775668
    [Abstract] [Full Text] [Related]

  • 27. Analysis of the postprandial lipid metabolism: use of a 3-point test.
    Guerci B, Paul JL, Hadjadj S, Durlach V, Vergès B, Attia N, Girard-Globa A, Drouin P.
    Diabetes Metab; 2001 Sep 31; 27(4 Pt 1):449-57. PubMed ID: 11547218
    [Abstract] [Full Text] [Related]

  • 28. Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients.
    Liu L, Zhao SP, Wen T, Zhou HN, Hu M, Li JX.
    Coron Artery Dis; 2008 May 31; 19(3):145-51. PubMed ID: 18418230
    [Abstract] [Full Text] [Related]

  • 29. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK, Hajer GR, van der Graaf Y, Dallinga-Thie GM, Visseren FL.
    J Cardiovasc Pharmacol; 2008 Aug 31; 52(2):145-50. PubMed ID: 18670365
    [Abstract] [Full Text] [Related]

  • 30. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis.
    Dod HS, Bhardwaj R, Sajja V, Weidner G, Hobbs GR, Konat GW, Manivannan S, Gharib W, Warden BE, Nanda NC, Beto RJ, Ornish D, Jain AC.
    Am J Cardiol; 2010 Feb 01; 105(3):362-7. PubMed ID: 20102949
    [Abstract] [Full Text] [Related]

  • 31. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS.
    Int J Cardiol; 2009 May 01; 134(1):52-8. PubMed ID: 18479768
    [Abstract] [Full Text] [Related]

  • 32. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation.
    de Roos NM, Siebelink E, Bots ML, van Tol A, Schouten EG, Katan MB.
    Eur J Clin Nutr; 2002 Jul 01; 56(7):674-9. PubMed ID: 12080409
    [Abstract] [Full Text] [Related]

  • 33. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E, Galicka-Latala D, Cieslik G, Rostoff P, Fedak D, Sieradzki J, Naskalski J, Piwowarska W.
    Diabetes Obes Metab; 2008 Sep 01; 10(9):719-25. PubMed ID: 17941871
    [Abstract] [Full Text] [Related]

  • 34. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
    Kovács I, Tarján J, Császár A.
    Orv Hetil; 2001 Apr 15; 142(15):775-9. PubMed ID: 11367862
    [Abstract] [Full Text] [Related]

  • 35. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH, Huang PH, Huang SS, Wu TC, Chen JW, Lin SJ.
    Coron Artery Dis; 2009 Jun 15; 20(4):267-73. PubMed ID: 19440065
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Bays H, Rhyne J, Stein E, Rotenberg K, Doyle R.
    Clin Ther; 2005 Jun 15; 27(6):715-27. PubMed ID: 16117978
    [Abstract] [Full Text] [Related]

  • 37. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G, Irish A, Chan D, Watts G.
    Am J Kidney Dis; 2007 Jun 15; 49(6):776-85. PubMed ID: 17533020
    [Abstract] [Full Text] [Related]

  • 38. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M, Esmaeili HA, Ferns GA.
    Clin Lab; 2007 Jun 15; 53(1-2):49-56. PubMed ID: 17323825
    [Abstract] [Full Text] [Related]

  • 39. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ, Li LD, Wu LM.
    Clin Exp Pharmacol Physiol; 2007 Jun 15; 34(1-2):27-35. PubMed ID: 17201732
    [Abstract] [Full Text] [Related]

  • 40. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
    Yunoki K, Nakamura K, Miyoshi T, Enko K, Kohno K, Morita H, Kusano KF, Ito H.
    Atherosclerosis; 2011 Aug 15; 217(2):486-91. PubMed ID: 21592480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.